TBXU Direxion Daily Biotech Top 5 Bull 2X ETF
This Direxion Daily Biotech Top 5 Bull 2X ETF aims to provide daily investment returns equivalent to 200% of the performance of the NYSE Biotechnology Top 5 Equal Weight Index, before factoring in its fees and expenses. Please note that the fund offers no assurance of consistently meeting its stated investment targets.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| TBXU | +34.6% | +25.2% | +54.5% | +51.4% | +21.7% | +12.5% |
| Equity average (4626 funds) | -2.1% | +2.7% | +87.6% | +61180.3% | +13.9% | +2.3% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$0 net.
No open-market insider buys in the holdings in the last 90 days.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | TBXU BIOEW5 SWAP ASSET LEG (BIOEW5CTL) | 24.89% |
| 2 | AMGN AMGEN INC | 4.93% |
| 3 | REGN REGENERON PHARMACEUTICALS | 4.89% |
| 4 | GILD GILEAD SCIENCES INC | 4.69% |
| 5 | VRTX VERTEX PHARMACEUTICALS INC | 4.22% |
| 6 | ARGX ARGENX SE - ADR | 3.95% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Sep 22, 2026 | $0.1420 |
| Jun 23, 2026 | $0.1110 |
| Mar 24, 2026 | $0.0990 |
| Dec 23, 2025 | $0.1010 |
| Dec 10, 2025 | $0.3110 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in TBXU in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error